Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension [0.03%]
降钙基因相关肽单克隆抗体治疗伴有活动性特发性颅内高压的头痛患者
Andreas Yiangou,James L Mitchell,Vivek Vijay et al.
Andreas Yiangou et al.
Background: Headache is the dominant factor for quality of life related disability in idiopathic intracranial hypertension (IIH) and typically has migraine-like characteristics. There are currently no evidence-based thera...
European Headache Federation recommendations for placebo and nocebo terminology [0.03%]
欧洲头痛联盟对安慰剂和反安慰剂术语的建议
Dimos D Mitsikostas,Charlotte Blease,Elisa Carlino et al.
Dimos D Mitsikostas et al.
Background and aim: Despite recent publications, practitioners remain unfamiliar with the current terminology related to the placebo and nocebo phenomena observed in clinical trials and practice, nor with the factors that...
Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study [0.03%]
新型冠状病毒疾病2019(COVID-19)大流行对偏头痛患者的影响：一项基于网络的调查研究
Jasem Y Al-Hashel,Ismail Ibrahim Ismail
Jasem Y Al-Hashel
Background: Since the declaration COVID-19 as a pandemic, healthcare systems around the world have faced a huge challenge in managing patients with chronic diseases. Patients with migraine were specifically vulnerable to ...
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study [0.03%]
fremanezumab对慢性偏头痛患者药物过量使用的影响：HALO CM研究的亚组分析
Stephen D Silberstein,Joshua M Cohen,Michael J Seminerio et al.
Stephen D Silberstein et al.
Background: We evaluated the efficacy of fremanezumab, a fully humanized monoclonal antibody that selectively targets calcitonin gene-related peptide, in patients with chronic migraine (CM) with and without medication ove...
Correction to: Increased risk of tinnitus following a trigeminal neuralgia diagnosis: a one-year follow-up study [0.03%]
校正：三叉神经痛诊断后发生耳鸣的风险增加：一项为期一年的随访研究
Yen-Fu Cheng,Sudha Xirasagar,Tzong-Han Yang et al.
Yen-Fu Cheng et al.
An amendment to this paper has been published and can be accessed via the original article.
Published Erratum
The journal of headache and pain. 2020 Sep 18;21(1):113. DOI:10.1186/s10194-020-01184-5 2020
Haemodynamic activity characterization of resting state networks by fractal analysis and thalamocortical morphofunctional integrity in chronic migraine [0.03%]
慢性偏头痛患者静息态网络的分形分析及丘脑皮层形态功能完整性的血流动力学活性特征
Camillo Porcaro,Antonio Di Renzo,Emanuele Tinelli et al.
Camillo Porcaro et al.
Background: Chronic migraine (CM) can be associated with aberrant long-range connectivity of MRI-derived resting-state networks (RSNs). Here, we investigated how the fractal dimension (FD) of blood oxygenation level depen...
Impaired effective functional connectivity of the sensorimotor network in interictal episodic migraineurs without aura [0.03%]
无先兆间歇期偏头痛患者感觉运动网络的有效功能连接受损
Heng-Le Wei,Jing Chen,Yu-Chen Chen et al.
Heng-Le Wei et al.
Background: Resting-state functional magnetic resonance imaging (Rs-fMRI) has confirmed sensorimotor network (SMN) dysfunction in migraine without aura (MwoA). However, the underlying mechanisms of SMN effective functiona...
Burden of migraine among Japanese patients: a cross-sectional National Health and Wellness Survey [0.03%]
日本偏头痛患者的疾病负担：一项全国健康和幸福感横断面调查
Shoji Kikui,Yirong Chen,Hiroshi Todaka et al.
Shoji Kikui et al.
Background: Limited studies have measured the burden of migraine in Japan. This study aimed at estimating the disease burden of migraine in Japan and identifying factors associated with the burden using the 2017 National ...
Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study [0.03%]
弗瑞美珠单抗治疗在患者报道的多个领域改善的成果：一项患者调查研究
Dawn C Buse,Sanjay K Gandhi,Joshua M Cohen et al.
Dawn C Buse et al.
Background: The long-term safety and efficacy of fremanezumab were evaluated in a 52-week extension study (NCT02638103). Patient satisfaction with fremanezumab, dosing preferences, and patient-reported outcomes were asses...
The prevalence of headache disorders in children and adolescents in Ethiopia: a schools-based study [0.03%]
埃塞俄比亚儿童和青少年头痛障碍的流行率：基于学校的调查研究
Yared Zenebe Zewde,Mehila Zebenigus,Hanna Demissie et al.
Yared Zenebe Zewde et al.
Background: The Global Burden of Disease (GBD) study establishes headache as the second-highest cause of disability worldwide. Because most headache data in GBD are from adults, leading to underestimation of headache-attr...